Skip to content
★ Sign in to follow
郑

郑志国

Board Director
Director
奥翔药业
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€19.6M

Latest filing published 14 Dec 2022 for 奥翔药业, €19.5M.

Filing timeline

BuySale
郑志国

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

郑志国: trading record in brief

郑志国 (board member) discloses dealings in 奥翔药业 to SSE / SZSE (CSRC). The record holds 2 filings, for trades running from 26 July 2022 to 14 December 2022.

Sales make up the whole of the open-market record (2 sales, €19.6M).

The latest filing, published on 14 December 2022, reports an open-market sale of €19.5M in 奥翔药业. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 郑志国

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    董事,高级管理人员Executives奥翔药业
    144M CNY30SSE
    5,000,000 shares99.4% of flowA股XSHGSSE:173000006130584160
  • ▼
    董事,高级管理人员Executives奥翔药业
    865,800 CNY22SSE
    20,000 shares0.6% of flowA股XSHGSSE:173000005714677500

2 of 2 declarations